This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
New Serological Immunity Tests - COVID-19
New Serological Immunity Tests - COVID-19
CMIL, in collaboration with its partner SYNLAB, announces its latest tool to help combat the current pandemic of COVID-19, the Serological Immunity Tests.
Serological Immunity Tests allow our patients to identify if they have already had contact with the SARS-CoV-2 virus, assessing their immune response, that is, assessing whether their organism has developed antibodies against the virus, increasing their protection against it, thus facilitating the resumption of their professional and social activities with greater confidence.
From the Serological Tests it is possible to measure IgM and IgG antibodies in the laboratory, allowing the diagnosis of new cases of infection and / or attesting to the immune response to COVID-19. IgM antibodies, since they appear at an earlier stage, allow the identification of infected patients on average, 7 days after infection. IgG antibodies, since they appear at a later stage (usually from the 2nd week, reaching their peak at 60 days), are considered the most important in the follow-up of the immune response, and may be the only way to identify individuals who have been infected, with or without clinical manifestations of the disease.
At the International Medical Clinic of Lisbon, patients will have access to two test modalities:
– Serological test – IgG + IgM antibodies
– Serological test – IgG antibodies
After obtaining the test results, which requires between 24 to 48 hours:
– IgM positive patients should be tested for genome detection (RT-PCR) in order to confirm or not the existence of a positive infection.
– IgG positive patients have an immune response and therefore greater protection against the virus. It is important to note that, at the moment, the presence of IgG identifies the presence of an immune response, however, the current state of knowledge does not allow determining the duration of this immune response.
– patients without IgM or IgG antibodies should maintain active care, according to our National Health Agency (DGS), seeking to use a mask indoors or in close contact with other people, as well as regular measurement of body temperature in order to identify any changes.
For more information please contact our Clinic.